NuLife Study

Repromed is excited to be involved in trialling a new potential therapy that may improve IVF success.

This medication (NuLife) acts on the uterine lining (endometrium), and hopefully will make the lining more “receptive” to the embryo. This research will not involve IVF treatment or an embryo transfer and is not aiming to improve your health or your chances of getting pregnant.

Your participation can contribute to more knowledge about the activity of the new gel and the results of this study might help women fall pregnant more easily in the future.

If you are possibly interested and keen to help people fall pregnant more easily in the future, please click here for further details.